| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.72B | 47.44B | 45.64B | 32.38B | 29.39B | 21.40B |
| Gross Profit | 11.88B | 15.36B | 15.30B | 10.90B | 10.15B | 7.09B |
| EBITDA | 3.32B | 3.98B | 4.45B | 2.33B | 1.97B | 771.67M |
| Net Income | 1.82B | 2.34B | 2.27B | 992.59M | 649.58M | 11.71M |
Balance Sheet | ||||||
| Total Assets | 45.15B | 45.86B | 45.52B | 35.73B | 34.44B | 31.69B |
| Cash, Cash Equivalents and Short-Term Investments | 8.83B | 7.65B | 9.54B | 8.47B | 9.34B | 8.94B |
| Total Debt | 5.33B | 4.73B | 5.03B | 3.68B | 3.86B | 3.83B |
| Total Liabilities | 20.25B | 19.42B | 21.10B | 15.62B | 15.37B | 13.20B |
| Stockholders Equity | 24.81B | 26.31B | 24.33B | 20.11B | 19.07B | 18.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -839.21M | 1.08B | -360.57M | 2.19B | -169.36M |
| Operating Cash Flow | 0.00 | 944.36M | 3.14B | 290.48M | 2.60B | 1.13B |
| Investing Cash Flow | 0.00 | -2.03B | -2.70B | -446.18M | -1.93B | -1.74B |
| Financing Cash Flow | 0.00 | -906.85M | 70.42M | -450.54M | -445.90M | 366.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥549.39B | 11.76 | 8.51% | 2.25% | 3.33% | 9.57% | |
75 Outperform | ¥37.69B | 3.81 | ― | 3.56% | 3.03% | 160.39% | |
72 Outperform | ¥188.06B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
69 Neutral | ¥14.99B | 5.97 | ― | 4.20% | ― | ― | |
67 Neutral | ¥68.24B | 31.55 | 1.61% | 2.27% | 1.82% | -32.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥29.07B | 3.93 | ― | 2.94% | 0.41% | -51.02% |